Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti-epileptic Drugs for Pediatrics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-epileptic Drugs for Pediatricsmarket, defines the market attractiveness level of Anti-epileptic Drugs for Pediatrics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-epileptic Drugs for Pediatrics industry, describes the types of Anti-epileptic Drugs for Pediatrics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-epileptic Drugs for Pediatrics market and the development prospects and opportunities of Anti-epileptic Drugs for Pediatrics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-epileptic Drugs for Pediatrics market in Chapter 13.
By Player:
GW Pharmaceuticals
Zynerba
Insys
Mylan NV
Cephalon, Inc
Janssen Pharmaceuticals
Sunovion Pharmaceuticals Limited
Valeant Pharmaceuticals International, Inc
Sanofi SA
GlaxoSmithKline plc
Pfizer, Inc
Zogenix
UCB Pharma Limited
Novartis AG
By Type:
1st Generation
2nd Generation
3rd Generation
By End-User:
Hospitals
Retail pharmacies
Online pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-epileptic Drugs for Pediatrics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-epileptic Drugs for Pediatrics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-epileptic Drugs for Pediatrics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-epileptic Drugs for Pediatrics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-epileptic Drugs for Pediatrics Market Analysis and Outlook to 2022
-
7.1 Global Anti-epileptic Drugs for Pediatrics Consumption (2017-2022)
-
7.2 United States Anti-epileptic Drugs for Pediatrics Consumption (2017-2022)
-
7.3 Europe Anti-epileptic Drugs for Pediatrics Consumption (2017-2022)
-
7.4 China Anti-epileptic Drugs for Pediatrics Consumption (2017-2022)
-
7.5 Japan Anti-epileptic Drugs for Pediatrics Consumption (2017-2022)
-
7.6 India Anti-epileptic Drugs for Pediatrics Consumption (2017-2022)
-
7.7 South Korea Anti-epileptic Drugs for Pediatrics Consumption (2017-2022)
8 Region and Country-wise Anti-epileptic Drugs for Pediatrics Market Analysis and Outlook to 2028
-
8.1 Global Anti-epileptic Drugs for Pediatrics Consumption Forecast (2022-2028)
-
8.2 United States Anti-epileptic Drugs for Pediatrics Consumption Forecast (2022-2028)
-
8.3 Europe Anti-epileptic Drugs for Pediatrics Consumption Forecast (2022-2028)
-
8.4 China Anti-epileptic Drugs for Pediatrics Consumption Forecast (2022-2028)
-
8.5 Japan Anti-epileptic Drugs for Pediatrics Consumption Forecast (2022-2028)
-
8.6 India Anti-epileptic Drugs for Pediatrics Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-epileptic Drugs for Pediatrics Consumption Forecast (2022-2028)
9 Global Anti-epileptic Drugs for Pediatrics Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-epileptic Drugs for Pediatrics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 1st Generation Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 2nd Generation Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 3rd Generation Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-epileptic Drugs for Pediatrics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online pharmacies Consumption and Growth Rate (2017-2022)
10 Global Anti-epileptic Drugs for Pediatrics Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-epileptic Drugs for Pediatrics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 1st Generation Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 2nd Generation Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 3rd Generation Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-epileptic Drugs for Pediatrics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-epileptic Drugs for Pediatrics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-epileptic Drugs for Pediatrics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-epileptic Drugs for Pediatrics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-epileptic Drugs for Pediatrics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-epileptic Drugs for Pediatrics Market Competitive Analysis
-
14.1 GW Pharmaceuticals
-
14.1.1 GW Pharmaceuticals Company Details
-
14.1.2 GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Product and Service
-
14.2 Zynerba
-
14.2.1 Zynerba Company Details
-
14.2.2 Zynerba Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Zynerba Anti-epileptic Drugs for Pediatrics Product and Service
-
14.3 Insys
-
14.3.1 Insys Company Details
-
14.3.2 Insys Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Insys Anti-epileptic Drugs for Pediatrics Product and Service
-
14.4 Mylan NV
-
14.4.1 Mylan NV Company Details
-
14.4.2 Mylan NV Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Mylan NV Anti-epileptic Drugs for Pediatrics Product and Service
-
14.5 Cephalon, Inc
-
14.5.1 Cephalon, Inc Company Details
-
14.5.2 Cephalon, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Cephalon, Inc Anti-epileptic Drugs for Pediatrics Product and Service
-
14.6 Janssen Pharmaceuticals
-
14.6.1 Janssen Pharmaceuticals Company Details
-
14.6.2 Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Product and Service
-
14.7 Sunovion Pharmaceuticals Limited
-
14.7.1 Sunovion Pharmaceuticals Limited Company Details
-
14.7.2 Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Product and Service
-
14.8 Valeant Pharmaceuticals International, Inc
-
14.8.1 Valeant Pharmaceuticals International, Inc Company Details
-
14.8.2 Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Product and Service
-
14.9 Sanofi SA
-
14.9.1 Sanofi SA Company Details
-
14.9.2 Sanofi SA Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sanofi SA Anti-epileptic Drugs for Pediatrics Product and Service
-
14.10 GlaxoSmithKline plc
-
14.10.1 GlaxoSmithKline plc Company Details
-
14.10.2 GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Product and Service
-
14.11 Pfizer, Inc
-
14.11.1 Pfizer, Inc Company Details
-
14.11.2 Pfizer, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Pfizer, Inc Anti-epileptic Drugs for Pediatrics Product and Service
-
14.12 Zogenix
-
14.12.1 Zogenix Company Details
-
14.12.2 Zogenix Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Zogenix Anti-epileptic Drugs for Pediatrics Product and Service
-
14.13 UCB Pharma Limited
-
14.13.1 UCB Pharma Limited Company Details
-
14.13.2 UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Product and Service
-
14.14 Novartis AG
-
14.14.1 Novartis AG Company Details
-
14.14.2 Novartis AG Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Novartis AG Anti-epileptic Drugs for Pediatrics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-epileptic Drugs for Pediatrics
-
Figure Anti-epileptic Drugs for Pediatrics Picture
-
Table Global Anti-epileptic Drugs for Pediatrics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-epileptic Drugs for Pediatrics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-epileptic Drugs for Pediatrics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-epileptic Drugs for Pediatrics Consumption by Country (2017-2022)
-
Figure United States Anti-epileptic Drugs for Pediatrics Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-epileptic Drugs for Pediatrics Consumption and Growth Rate (2017-2022)
-
Figure China Anti-epileptic Drugs for Pediatrics Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-epileptic Drugs for Pediatrics Consumption and Growth Rate (2017-2022)
-
Figure India Anti-epileptic Drugs for Pediatrics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-epileptic Drugs for Pediatrics Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-epileptic Drugs for Pediatrics Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-epileptic Drugs for Pediatrics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-epileptic Drugs for Pediatrics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-epileptic Drugs for Pediatrics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-epileptic Drugs for Pediatrics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-epileptic Drugs for Pediatrics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-epileptic Drugs for Pediatrics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 1st Generation Consumption and Growth Rate (2017-2022)
-
Figure Global 2nd Generation Consumption and Growth Rate (2017-2022)
-
Figure Global 3rd Generation Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Retail pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global 1st Generation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 2nd Generation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 3rd Generation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-epileptic Drugs for Pediatrics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-epileptic Drugs for Pediatrics Export by Region (Top 5 Countries) (2017-2028)
-
Table GW Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Product and Service
-
Table Zynerba (Foundation Year, Company Profile and etc.)
-
Table Zynerba Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zynerba Anti-epileptic Drugs for Pediatrics Product and Service
-
Table Insys (Foundation Year, Company Profile and etc.)
-
Table Insys Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Insys Anti-epileptic Drugs for Pediatrics Product and Service
-
Table Mylan NV (Foundation Year, Company Profile and etc.)
-
Table Mylan NV Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan NV Anti-epileptic Drugs for Pediatrics Product and Service
-
Table Cephalon, Inc (Foundation Year, Company Profile and etc.)
-
Table Cephalon, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cephalon, Inc Anti-epileptic Drugs for Pediatrics Product and Service
-
Table Janssen Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Product and Service
-
Table Sunovion Pharmaceuticals Limited (Foundation Year, Company Profile and etc.)
-
Table Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Product and Service
-
Table Valeant Pharmaceuticals International, Inc (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Product and Service
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Anti-epileptic Drugs for Pediatrics Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Product and Service
-
Table Pfizer, Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer, Inc Anti-epileptic Drugs for Pediatrics Product and Service
-
Table Zogenix (Foundation Year, Company Profile and etc.)
-
Table Zogenix Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zogenix Anti-epileptic Drugs for Pediatrics Product and Service
-
Table UCB Pharma Limited (Foundation Year, Company Profile and etc.)
-
Table UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Anti-epileptic Drugs for Pediatrics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Anti-epileptic Drugs for Pediatrics Product and Service
-
